US Stock Alert: SELLAS Life Sciences plummets on November 18 due to $150 million additional issuance and profit-taking at high levels
Social Buzz: Wallstreetbets Stocks Mostly Higher Premarket Wednesday; GreenPower Motor, Nebius Group to Advance
SELLAS LIFE SCIENCES GROUP INC <SLS.O>: MAXIM GROUP RAISES TARGET PRICE TO $40 FROM $30
Sellas' GPS Cuts Death Risk 41% in Phase 3 Acute Myeloid Leukemia Trial
SELLAS Life Sciences Launches $150 Million Public Stock Offering
Sector Update: Healthcare Stocks Retreat Late Afternoon
Top Midday Gainers
Sector Update: Healthcare Stocks Retreat Tuesday Afternoon
Updated Version 3 - Seres vaccine extends patient survival in blood cancer clinical trials, stock price soars